Transcatheter tricuspid valve‐in‐valve in patients with transvalvular device leads
- 6 May 2015
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 87 (4) , E160-5
Abstract
Objective: To describe the effects of percutaneously implanted valve‐in‐valve in the tricuspid position for patients with pre‐existing transvalvular device leads.Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads.Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6‐month follow‐up, device lead parameters remain unchanged and transcatheter valve‐in‐valve function remains satisfactory.Conclusions: Transcatheter tricuspid valve‐in‐valve is feasible in patients with pre‐existing transvalvular devices leads. Further study is required to determine the long‐term clinical implications of this treatment approach.Keywords
This publication has 6 references indexed in Scilit:
- Transcatheter valve-in-valve implantation in the tricuspid positionEuroIntervention, 2014
- Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical ValvesJAMA, 2014
- Transvenous, Antegrade Melody Valve-in-Valve Implantation for Bioprosthetic Mitral and Tricuspid Valve DysfunctionJACC: Cardiovascular Interventions, 2013
- 5-Year Experience With Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve DysfunctionJACC, 2013
- Early percutaneous valve failure within bioprosthetic tricuspid tissue valve replacementsCatheterization and Cardiovascular Interventions, 2012
- Bioprosthetic Tricuspid Valve Regurgitation Associated With Pacemaker or Defibrillator Lead ImplantationJACC, 2012